... diagnosis andmanagementofheadandneckcancer Overview of treatment of the primary tumour andneck This section addresses the first line treatment ofheadandneckcancerManagementof recurrent ... the recognition andmanagementof acute and late radiation toxicity 29 diagnosis andmanagementofheadandneckcancer 10 Treatment: palliation of incurable disease Headandneckcancer may be ... on base of tongue or soft palate) 39 diagnosis andmanagementofheadandneckcancer Radiotherapy delivered postoperatively to the primary site and/ or neck in patients at highriskof locoregional...
... ALL HEADANDNECK CANCERS REDUCING RISK The riskof having headandneckcancer can be reduced by: B B not smoking or chewing tobacco C increasing the intake of fruit and vegetables ... tongue floor of mouth mucosal surface of the lip DIAGRAM OF THE HEADANDNECK Oral cavity Oropharynx Larynx Hypopharynx ALL HEADANDNECK CANCERS DIAGRAM OF THE LYMPH NODES LEVELS IN THE NECK I II ... recurrent headandneck cancer, where CT/MRI does not demonstrate a clear cut recurrence HISTOPATHOLOGY REPORTING C Histopathology reporting of specimens from the primary site ofheadandneck cancer...
... Pruet CW: Standardizing neck dissection terminology Offcial report of the Academy’s committee for headandneck surgery and oncology Arch Otolaryngol HeadNeck Surg 1991, 117:601-605 20 Candela FC, ... Remmert et al [22] analysed 405 patients with headandneck carcinoma and found no skip metastases A series of the HeadandNeck Service at Memorial Vorwerk and Hess Radiation Oncology 2011, 6:97 http://www.ro-journal.com/content/6/1/97 ... of NM of all headandneck regions, but the overall incidence of NM for N+ patients is still high with more than 30% [7,22,24,31] In level IIA, II and III the relative incidence of NM is higher...
... in headandneck cancers Cancer Radiother 2003, 7(1):62-72 Novaes PERS, Gentil AC, Lima CGB Jr, Pellizzon ACA, Kowalski LP: Possibilities ofhigh dose rate brachytherapy on treatment ofheadand ... LP: Interstitial high- dose-rate brachytherapy combined with cervical dissection on headandneckcancerHeadNeck 2005, 27(12):1035-41 Mazeron JJ, Noel G, Simon JM: Headandneck brachytherapy ... concomitant chemotherapy and radiotherapy regimen for squamous cell headandneck cancer: a systematic review of the published literature with subgroup analysis HeadNeck 2001, 23:579-589 Hinerman...
... a result of a high probability of perioperative myocardial ischaemia This usually accounts for between 10% and 20% of the total population of high- risk patients Ideally, this form ofmanagement ... be commenced before surgery and continued for a minimum of hours postoperatively A number of methods of cardiac output measurement are now available, and the use of GDT no longer necessitates ... trial of supranormal values of survivors as therapeutic goals in high- risk surgical patients Chest 1988, 94: 1176-1186 Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of...
... trial of supranormal values of survivors as therapeutic goals in high- risk surgical patients Chest 1988, 94: 1176-1186 Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of ... now happened and followed a period of detailed discussion and education The protocol now in use is largely based on that used in the study and is run by the nurse assigned to the care of the patient ... increase of oxygen delivery on mortality in high- risk surgical patients J Am Med Assoc 1993, 270:2699-2707 Wilson J, Woods I, Fawcett J, Whall R, Dibb W, Morris C, McManus E: Reducing the riskof major...
... Guide to NECK DISSECTION CLASSIFICATION AND TNM STAGING OFHEADANDNECKCANCER Committee for HeadandNeck Surgery and Oncology American Academy of Otolaryngology– HeadandNeck Surgery Neck Dissection ... of: Pocket guide to neck dissection classification and TNM staging ofheadandneckcancer / Committee for Neck Dissection Classification, American HeadandNeck Society [and] Committee for Head ... III Sharma, Anand K IV Kies, Merrill S V American Academy of Otolaryngology HeadandNeck Surgery Committee for HeadandNeck Surgery and Oncology VI American HeadandNeck Society Neck Dissection...
... Figures and 4) Discussion During and after therapy of malignant diseases of the headand neck, communication skills are of special interest Until now, no objective method with low effort and costs ... techniques and was tested on speech of patients with different but significant extents of speech disorder (dysglossia) and voice disorder (dysphonia) after the treatment for headandneckcancer Speech ... description of morphologic impairment by endoscopic and imaging methods and the standardized perceptual evaluation of the individual handicap ASR will enable precise evaluations of speech and voice...
... for locally advanced headandneckcancer N Engl J Med 2004, 350:1945-1952 13 Cooper JS, Bernier J: Rationale for triage in the postoperativemanagementofheadandneck cancers Oncology 2005, ... patients with advanced headandneckcancer who receive chemotherapy and radiation therapy Radiology 1996, 201:675-680 Wood K: Audit of nutritional guidelines for headandneckcancer patients undergoing ... pilot study of longitudinal serum cytokine and angiogenesis factor levels as markers of therapeutic response and survival in patients with headandneck squamous cell carcinoma HeadNeck 2005,...
... in headandneckcancer patients who achieved locoregional control HeadNeck 2000, 22:680-686 27 Alvi A, Johnson JT: Development of distant metastasis after treatment of advanced-stage headand ... advanced-stage headandneckcancerHeadNeck 1997, 19:500-505 28 Mazer TM, Robbins KT, McMurtrey MJ, Byers RM: Resection of pulmonary metastases from squamous carcinoma of the headandneck Am J Surg ... resection of pulmonary metastases ofheadandneckcancer that a resection of a solitary pulmonary metastasis resulted in long-term survival in selected patients [29] Since treatment after diagnosis of...
... highly conformal dose distribution and highly accurate dose-delivery to within a few mm for extracranial headandneck lesions [27] The practical advantage is in terms of the short duration of ... Williamson SK, Von Hoff DD: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the headand neck: a Southwest ... Radiotherapy for Locally Recurrent Head- and- Neck Tumors Int J Radiat Oncol Biol Phys 14 Langlois D, Eschwege F, Kramar A, Richard JM: Reirradiation of the headandneck cancers Radiother Oncol 1985,...
... country field study of the EORTC QLQ-C30 (version 3.0) and the headandneckcancer specific module (EORTC QLQ-H&N35) in headandneck patients EORTC Quality of Life Group Eur J Cancer 2000, 36:1796-1807 ... radiotherapy for headandneck cancer, the major salivary glands frequently receive a high radiation dose A high dose on the salivary glands results in a reduction of salivary output and a change ... Jannert M, Westin T, Kaasa S: Quality of life in headandneckcancer patients: validation of the European Organization for Research and Treatment ofCancer Quality of Life Questionnaire-H&N35 J Clin...
... therapy for headandneck carcinoma Oncologist 2007, 12:565-8 Rosenthal DI, Lewin JS, Eisbruch A: Prevention and treatment of dysphagia and aspiration after chemoradiation for headandneckcancer ... with headandneckcancerHeadNeck 2000, 22:474-82 Stenson KM, MacCracken E, List M, Haraf DJ, Brockstein B, Weichselbaum R, Vokes EE: Swallowing function in patients with headandneckcancer ... EE, Newman LA, Liu D: Site of disease and treatment protocol as correlated of swallowing function in patients with headandneckcancer treated with chemoradiaiton HeadNeck 2006, 28:64-73 Langendijk...
... approach in a set of 79 headandneckcancer patients We observed that RIA values increased with radiation Table Toxicity observed in 79 HeadandNeckcancer patients dose (0, 1, and Gy) and fitted ... 18 Munter MW, Karger CP, Hoffner SG, Hof H, Thilmann C, Rudat V, Nill S, Wannenmacher M, Debus J: Evaluation of salivary gland function after treatment of head- and- neck tumors with intensity-modulated ... Strnad V: Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head- and- neck cancer: 2year follow-up of a prospective, randomized, phase III...
... for HeadandNeck Surgery and Oncology, American Academy of Otolaryngology -Head andNeck Surgery: Neck dissection Classificaton Update: Revisions Proposed by the American HeadandNeck Society and ... irradiation of the neckand the oro- and nasopharynx Pretreatment evaluation consisted of a complete history and physical examination including endoscopy in unresectable cancers and detailed surgical and ... Henriksson R: Parotid gland function during and following radiotherapy of malignancies in the headand neck: A consecutive study of salivary flow and patient discomfort Eur J Cancer 1992, 28:457-62...
... joint HeadandNeck Surgery, or Head, Neckand Maxillofacial Surgery, both at the University Hospital of Zurich Similarly, histopathologic examinations and diagnosis have been performed by headand ... Garden AS, Frankenthaler RA, et al.: Evaluation of the dose for postoperative radiation therapy ofheadandneck cancer: first report of a prospective randomized trial Int J Radiat Oncol Biol Phys ... address the validity and dose ofpostoperative radiation, the impact of accelerating postoperative radiation, and the importance of the overall treatment time on outcome in 302 and 213 patients,...
... country field study of the EORTC QLQ-C30 (version 3.0) and the headandneckcancer specific module (EORTC QLQ-H&N35) in headandneck patients EORTC Quality of Life Group Eur J Cancer 2000, 36:1796-1807 ... Jannert M, Westin T, Kaasa S: Quality of life in headandneckcancer patients: validation of the European Organization for Research and Treatment ofCancer Quality of Life Questionnaire-H&N35 J Clin ... with head- andneck cancer [11] It contains seven symptom scales and six symptom items It is designed to be used together with the core QLQ-C30 and has been validated in 622 head- andneck cancer...
... Expression Profiles Identify Epithelial-to-Mesenchymal Transition and Activation of Nuclear Factor-{kappa}B Signaling as Characteristics of a High- riskHeadandNeck Squamous Cell Carcinoma Cancer ... T, et al.: Genetic and expression profiles of squamous cell carcinoma of the headandneck correlate with cisplatin sensitivity and resistance in cell lines and patients Clin Cancer Res 2004, 10(24):8204-8213 ... Ricker JL, Chen Z, Van Waes C: Role of activated nuclear factor-kappaB in the pathogenesis and therapy of squamous cell carcinoma of the headandneckHeadNeck 2007, 29(10):959-971 Lee TL, Yang...
... maintenance of medical hardware’s partly because of lack of spare parts and the technical knowhow in sub-Saharan Africa 10 HeadandNeckCancer The future direction in headandneckcancermanagement ... 0.5% of all human malignancies with an incidence of less than per 100,000 population and constituting only 3%–5% of all 14 HeadandNeckCancerheadandneck cancers (Cooper et al., 2009; Hoffman ... Southeast China and Taiwan, headandneck cancer, specifically nasopharyngeal cancer is the most common cause of death in young man Headandneckcancer requires a multidisciplinary approach and a clear...